# Fresenius Kabi AB, Uppsala, Sweden – FDA Inspections

Source: https://www.keypedia.com/companies/fresenius-kabi-ab/95acd39b-72be-48a9-aa55-38713a33c8cc

> Inspection records and compliance data for Fresenius Kabi AB in Uppsala. 8 FDA inspections on record, 1 Form 483, last inspected April 21, 2023.

---

## Details

- Name: Fresenius Kabi AB
- FEI Number: 3002631703
- Business Operations: API MANUFACTURE, FDF MANUFACTURE
- Address Line 1: Rapsgatan 7
- City: Uppsala
- Country Name: Sweden
- Address: Rapsgatan 7, Uppsala, Sweden
- Country: Sweden

## Related Documents

- FDA Inspection 1238177 - Fresenius Kabi AB - 2023-04-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 21, 2023
- FDA Inspection 1238177 - Fresenius Kabi AB - 2023-04-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 21, 2023
- FDA Inspection 1155467 - Fresenius Kabi AB - 2020-10-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 15, 2020
- [FDA Inspection 1099421 - Fresenius Kabi AB - 2018-10-16](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-ab/601d4a6e-431f-4514-affd-3f8945416a3c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2018
- [FDA Inspection 1005000 - Fresenius Kabi AB - 2017-02-07](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-ab/5335bdf2-a6c2-4615-9a8d-e8c7eb43064f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2017
- FDA Inspection 1005000 - Fresenius Kabi AB - 2017-02-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2017
- FDA Inspection 925969 - Fresenius Kabi AB - 2015-03-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 20, 2015
- FDA Inspection 876533 - Fresenius Kabi AB - 2014-04-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 11, 2014
- FDA Inspection 876533 - Fresenius Kabi AB - 2014-04-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 11, 2014
- FDA Inspection 802513 - Fresenius Kabi AB - 2012-09-25 — classification: No Action Indicated (NAI), source: FDA, date: September 25, 2012

## Related Companies

- [Syngene International Ltd.](https://www.keypedia.com/companies/syngene-international-ltd/11ddfe19-cf6b-48b5-b7ab-8e3236ac3636)
- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/404ebab5-56a6-486d-bb01-be43a9478fad)
- [Indena S.p.A.](https://www.keypedia.com/companies/indena-spa/bc7187ac-74c4-4f04-bd1c-0d888424e076)
- [Hovione Limited](https://www.keypedia.com/companies/hovione-limited/cf05e9e2-8ff4-41e2-a547-34c4f03eaef5)
- [Siegfried USA, LLC](https://www.keypedia.com/companies/siegfried-usa-llc/0e21650d-f620-4e29-a62d-aa4ecd79cef2)
- [FIS - Fabbrica Italiana Sintetici S.p.A.](https://www.keypedia.com/companies/fis-fabbrica-italiana-sintetici-spa/b9e7c30e-9955-4095-aae6-e40efd92c3c0)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/a659fe71-9183-4c7c-96ca-9214c6a9c177)
- [Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a)
- [Janssen Biotech, Inc.](https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57)
- [Genzyme Flanders](https://www.keypedia.com/companies/genzyme-flanders/5f71d574-8097-4cd8-9254-2f8b85700e59)
